Literature DB >> 26670084

Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion.

Bo-Ryoung Choi1, Dong-Hee Kim1, Dong Bin Back1, Chung Hwan Kang1, Won-Jin Moon1, Jung-Soo Han1, Dong-Hee Choi1, Kyoung Ja Kwon1, Chan Young Shin1, Bo-Ram Kim1, Jongmin Lee1, Seol-Heui Han1, Hahn Young Kim2.   

Abstract

BACKGROUND AND
PURPOSE: Chronic cerebral hypoperfusion can lead to ischemic white matter injury resulting in vascular dementia. To characterize white matter injury in vascular dementia, we investigated disintegration of diverse white matter components using a rat model of chronic cerebral hypoperfusion.
METHODS: Chronic cerebral hypoperfusion was modeled in Wistar rats by permanent occlusion of the bilateral common carotid arteries. We performed cognitive behavioral tests, including the water maze task, odor discrimination task, and novel object test; histological investigation of neuroinflammation, oligodendrocytes, myelin basic protein, and nodal or paranodal proteins at the nodes of Ranvier; and serial diffusion tensor imaging. Cilostazol was administered to protect against white matter injury.
RESULTS: Diverse cognitive impairments were induced by chronic cerebral hypoperfusion. Disintegration of white matter was characterized by neuroinflammation, loss of oligodendrocytes, attenuation of myelin density, structural derangement at the nodes of Ranvier, and disintegration of white matter tracts. Cilostazol protected against cognitive impairments and white matter disintegration.
CONCLUSIONS: White matter injury induced by chronic cerebral hypoperfusion can be characterized by disintegration of diverse white matter components. Cilostazol might be a therapeutic strategy against white matter disintegration in patients with vascular dementia.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cilostazol; dementia, vascular; models, animal; white matter

Mesh:

Substances:

Year:  2015        PMID: 26670084     DOI: 10.1161/STROKEAHA.115.011679

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  40 in total

Review 1.  Rodent Models of Vascular Cognitive Impairment.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey Thompson; Gary A Rosenberg
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

Review 2.  Advances in chronic cerebral circulation insufficiency.

Authors:  Da Zhou; Ran Meng; Si-Jie Li; Jing-Yuan Ya; Jia-Yue Ding; Shu-Ling Shang; Yu-Chuan Ding; Xun-Ming Ji
Journal:  CNS Neurosci Ther       Date:  2017-11-15       Impact factor: 5.243

3.  High-Mobility Group Box 1 Neutralization Prevents Chronic Cerebral Hypoperfusion-Induced Optic Tract Injuries in the White Matter Associated with Down-regulation of Inflammatory Responses.

Authors:  Yue Hei; Xin Zhang; Rong Chen; Yuefei Zhou; Dakuan Gao; Weiping Liu
Journal:  Cell Mol Neurobiol       Date:  2019-06-13       Impact factor: 5.046

4.  Icariside II affects hippocampal neuron axon regeneration and improves learning and memory in a chronic cerebral hypoperfusion rat model.

Authors:  Tao Liu; Fang He; Jiahong Yan; Wei Kuang; Changyin Yu
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

Review 5.  Roles of glial ion transporters in brain diseases.

Authors:  Shanshan Song; Lanxin Luo; Baoshan Sun; Dandan Sun
Journal:  Glia       Date:  2019-08-16       Impact factor: 7.452

Review 6.  Mapping the collaterome for precision cerebrovascular health: Theranostics in the continuum of stroke and dementia.

Authors:  David S Liebeskind
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-30       Impact factor: 6.200

7.  Acupuncture inhibits TXNIP-associated oxidative stress and inflammation to attenuate cognitive impairment in vascular dementia rats.

Authors:  Si-Qi Du; Xue-Rui Wang; Wen Zhu; Yang Ye; Jing-Wen Yang; Si-Ming Ma; Cai-Shuo Ji; Cun-Zhi Liu
Journal:  CNS Neurosci Ther       Date:  2017-11-06       Impact factor: 5.243

8.  Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway.

Authors:  Chuan Qin; Wen-Hui Fan; Qian Liu; Ke Shang; Madhuvika Murugan; Long-Jun Wu; Wei Wang; Dai-Shi Tian
Journal:  Stroke       Date:  2017-11-07       Impact factor: 7.914

Review 9.  The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis.

Authors:  Seemant Chaturvedi; Marc Chimowitz; Robert D Brown; Brajesh K Lal; James F Meschia
Journal:  Neurology       Date:  2016-09-28       Impact factor: 9.910

10.  CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses.

Authors:  Dan-Dan Liu; Xia Yuan; Shi-Feng Chu; Chen Chen; Qian Ren; Piao Luo; Mei-Yu Lin; Sha-Sha Wang; Tian-Bi Zhu; Qi-di Ai; Ying-da Zang; Dong-Ming Zhang; Xin He; Zhi-Hua Huang; Hong-Shuo Sun; Zhong-Ping Feng; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.